Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Completion of 2nd term of Independent Director

Emcure Ref: EPL/CS/SE/0062/2026 Date: July 21, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400 051 Mumbai- 400 001 Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE Dear Sir/Madam, Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Completion of 2nd term of Independent Director Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), we hereby inform that Mr. P.S. Jayakumar (DIN: 01173236) is completing his 2nd consecutive term as an Independent Director and consequently ceases to be a Director of the Company, with effect from close of business hours on July 21, 2026. Consequent to his cessation as an Independent Director, Mr. Jayakumar also ceases to be the Chairman/Member of the following Board Committees of the Company, with effect from July 21, 2026: 1. Audit Committee – Chairman 2. Nomination and Remuneration Committee – Member 3. Risk Management Committee - Member The Board places on record its appreciation for the contributions made by Mr. Jayakumar during his tenure as Independent Director of the Company. You are requested to take the above information on your records. Thanking you, For Emcure Pharmaceuticals Limited Amruta Yangalwar Company Secretary & Compliance Officer ICSI Membership Number: A25687 Emcure Pharmaceuticals Limited Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251